颈动脉斑块RADS分层与内膜剥脱术对比支架术的结局相关性
该回顾性研究纳入636例颈动脉干预患者(CEA 290例,CAS 346例),用Plaque-RADS评估斑块特征。中位随访29个月,总卒中复发94例(14.8%),CEA组30例(10.3%)低于CAS组64例(18.5%)。Plaque-RADS 4预测准确性优于其他影像特征,且Plaque-RADS 4患者中CEA无事件生存显著优于CAS。
要点
- Plaque-RADS 4预测卒中复发的C-index和AUC显著优于其他影像特征(均P<.05)。
- Plaque-RADS 4(HR 3.683)和CAS治疗(HR 1.630)为卒中复发的独立预测因素。
- Plaque-RADS 4患者中CEA无事件生存显著优于CAS(P=.004),RADS 3者无显著差异。
核心结论
- 颈动脉Plaque-RADS对主要结局的预测准确性优于单个斑块特征。
- 在高风险斑块(Plaque-RADS 4)患者中,CEA可能比CAS提供更好的结局。
研究设计与样本
- 回顾性研究,纳入636例接受颈动脉干预的患者,其中CEA 290例、CAS 346例。
- 使用Plaque-RADS评估斑块特征,采用AUC分析及DeLong检验比较预测准确性。
- 采用单因素和多因素分析识别卒中复发相关因素,并比较不同Plaque-RADS评分患者中CEA与CAS的无事件生存。
主要发现
- 中位随访29个月(四分位距12-51个月),总卒中复发94例(14.8%),CEA组30例(10.3%)vs CAS组64例(18.5%)。
- Plaque-RADS 4分类预测主要结局的C-index值和AUC显著高于所有其他影像特征(均P<.05)。
- 多因素Cox回归显示Plaque-RADS 4(HR 3.683,95%CI 2.217-4.520,P<.001)和CAS治疗(HR 1.630,95%CI 1.055-2.520,P=.028)为卒中复发的独立预测因素。
- Plaque-RADS 4患者中CEA的无事件生存显著高于CAS(P=.004),而Plaque-RADS 3患者中CEA与CAS无显著差异(P=.639)。
临床怎么用
- Plaque-RADS可用于颈动脉狭窄患者的斑块风险评估,Plaque-RADS 4提示卒中复发风险较高。
- 对于Plaque-RADS 4的高风险斑块患者,CEA可能较CAS提供更好的无事件生存。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Carotid endarterectomy (CEA) and carotid artery stenting (CAS) are the main treatment options for carotid atherosclerotic stenosis; however, determining the most appropriate intervention remains challenging. This study evaluates whether the Carotid Plaque-Reporting and Data System (RADS) enhances risk stratification for ipsilateral recurrent stroke after CAS or CEA in patients with anterior circulation ischemic stroke and investigates whether stratification based on plaque characteristics can help to identify patient subgroups more likely to benefit from CEA vs CAS. METHODS: This retrospective study included 636 patients who underwent carotid interventions, comprising 290 CEA and 346 CAS cases. Plaque characteristics were assessed using Plaque-RADS. Area under the curve (AUC) analysis with the DeLong test was used to compare predictive accuracy. Univariate and multivariate analyses were performed to identify factors associated with stroke recurrence, and event-free survival was compared between CEA and CAS in patients with different Plaque-RADS scores. RESULTS: The median follow-up duration for the overall cohort was 29 months (interquartile range, 12-51 months). Stroke recurrence occurred in 94 patients (14.8%) overall: 30 patients (10.3%) in the CEA group and 64 patients (18.5%) in the CAS group. The Carotid Plaque-RADS 4 classification outperformed all other imaging features, showing significantly higher C-index values and larger AUCs for primary outcome prediction (all P < .05). Multivariate Cox regression revealed that Plaque-RADS 4 (hazard ratio, 3.683; 95% confidence interval, 2.217-4.520; P < .001) and CAS treatment (hazard ratio, 1.630; 95% confidence interval, 1.055-2.520; P = .028) were independent predictors of stroke recurrence. For patients with Plaque-RADS 4, event-free survival was significantly higher with CEA compared with CAS (P = .004), whereas no significant difference was observed between CEA and CAS in patients with Plaque-RADS 3 (P = .639). CONCLUSIONS: Carotid Plaque-RADS demonstrated superior predictive accuracy for primary outcomes compared with individual plaque characteristics. CEA may provide better outcomes than CAS in patients with high-risk plaques (Plaque-RADS 4).
引用
- Huang Z, Cheng XQ, Lu RR, et al. Correlation of plaque vulnerability stratified by Carotid Plaque-Reporting and Data System with outcomes of endarterectomy vs stenting. J Vasc Surg. 2025. PMID: 40505824. doi:10.1016/j.jvs.2025.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。